Filter

Refine by collections

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 1,146 items for :

  • Refine by access: All content x
Clear All
Cristina Capatina Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford OX3 7LE, UK

Search for other papers by Cristina Capatina in
Google Scholar
PubMed Close
,
Georgia Ntali Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford OX3 7LE, UK

Search for other papers by Georgia Ntali in
Google Scholar
PubMed Close
,
Niki Karavitaki Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford OX3 7LE, UK

Search for other papers by Niki Karavitaki in
Google Scholar
PubMed Close
, and
Ashley B Grossman Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford OX3 7LE, UK

Search for other papers by Ashley B Grossman in
Google Scholar
PubMed Close

genetic data, these tumours are being diagnosed by endocrinologists and oncologists, but much of the published literature is in more specialised ENT or surgical journals. We think that it will be useful to survey current data on the management of these

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-13-0223
Volume/Issue:
Volume 20: Issue 5
Free access
Jaydira Del Rivero Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA

Search for other papers by Jaydira Del Rivero in
Google Scholar
PubMed Close
,
Josh Mailman NorCal CarciNET Community, Oakland, California, USA

Search for other papers by Josh Mailman in
Google Scholar
PubMed Close
,
Michael W Rabow Department of Internal Medicine, Division of Palliative Medicine, University of California, San Francisco, San Francisco, California, USA

Search for other papers by Michael W Rabow in
Google Scholar
PubMed Close
,
Jennifer A Chan Harvard Medical School, Program in Carcinoid and Neuroendocrine Tumors, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Search for other papers by Jennifer A Chan in
Google Scholar
PubMed Close
,
Sarah Creed Good Shepherd Community Care, Harvard Kennedy School, Natick, Massachusetts, USA

Search for other papers by Sarah Creed in
Google Scholar
PubMed Close
,
Hagen F Kennecke Providence Cancer Institute Franz Clinic, Portland Providence Medical Center, Portland, Oregon, USA

Search for other papers by Hagen F Kennecke in
Google Scholar
PubMed Close
,
Janice Pasieka Department of Surgery, Section of General Surgery, University of Calgary, Cumming School of Medicine, Calgary, Canada

Search for other papers by Janice Pasieka in
Google Scholar
PubMed Close
,
Jennifer Zuar Department of Internal Medicine, Division of Geriatrics and Palliative Medicine, Alpert Medical School, Providence, Rhode Island, USA

Search for other papers by Jennifer Zuar in
Google Scholar
PubMed Close
,
Simron Singh Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Search for other papers by Simron Singh in
Google Scholar
PubMed Close
, and
Lauren Fishbein Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, Department of Biomedical Informatics, University of Colorado School of Medicine, Aurora, Colorado, USA

Search for other papers by Lauren Fishbein in
Google Scholar
PubMed Close

, integrative treatments, procedures, and NET-directed treatments in people with symptom-related NET. Treatment type (✓ if relatively specific to palliation of NET) Intervention Typical indication in people with NET Symptom management

Article Type:
Other
DOI:
https://doi.org/10.1530/ERC-22-0226
Volume/Issue:
Volume 30: Issue 7
Open access
C R C Pieterman Section of Surgical Endocrinology, Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by C R C Pieterman in
Google Scholar
PubMed Close
,
S M Sadowski Endocrine Surgery, Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by S M Sadowski in
Google Scholar
PubMed Close
,
J E Maxwell Department of Surgical Oncology, University of Texas MD Anderson Cancer Center

Search for other papers by J E Maxwell in
Google Scholar
PubMed Close
,
M H G Katz Department of Surgical Oncology, University of Texas MD Anderson Cancer Center

Search for other papers by M H G Katz in
Google Scholar
PubMed Close
,
K E Lines Academic Endocrine Unit, Radcliffe Department of Medicine, OCDEM, University of Oxford, Oxford, UK

Search for other papers by K E Lines in
Google Scholar
PubMed Close
,
C M Heaphy Departments of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Search for other papers by C M Heaphy in
Google Scholar
PubMed Close
,
A Tirosh Neuroendocrine Tumors Service, Division of Endocrinology, Metabolism and Diabetes, The Chaim Sheba Medical Center, and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

Search for other papers by A Tirosh in
Google Scholar
PubMed Close
,
J E Blau Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by J E Blau in
Google Scholar
PubMed Close
,
N D Perrier Section of Surgical Endocrinology, Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by N D Perrier in
Google Scholar
PubMed Close
,
M A Lewis Gastrointestinal Oncology, Intermountain Healthcare, Murray, Utah, USA
American Multiple Endocrine Neoplasia Support (AMENSupport), Maryville, Tennessee, USA

Search for other papers by M A Lewis in
Google Scholar
PubMed Close
,
J P Metzcar Association of Multiple Endocrine Neoplasia Disorders (AMEND), Bloomington, Indiana, USA
Departments of Intelligent Systems Engineering and Informatics, Indiana University, Bloomington, Indiana, USA

Search for other papers by J P Metzcar in
Google Scholar
PubMed Close
,
D M Halperin Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by D M Halperin in
Google Scholar
PubMed Close
,
R V Thakker Academic Endocrine Unit, Radcliffe Department of Medicine, OCDEM, University of Oxford, Oxford, UK

Search for other papers by R V Thakker in
Google Scholar
PubMed Close
, and
G D Valk Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by G D Valk in
Google Scholar
PubMed Close

) were present, as were representatives from the pharmaceutical industry and the Neuroendocrine Tumor Research Foundation (NETRF). In a case-based approach, participants addressed early detection, surveillance, prognostic factors and management of

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-19-0441
Volume/Issue:
Volume 27: Issue 8
Free access
Krystallenia I Alexandraki Department of Pathophysiology, Neuroendocrine Tumor Unit, Oxford Centre for Diabetes, National University of Athens, Greece

Search for other papers by Krystallenia I Alexandraki in
Google Scholar
PubMed Close
,
Gregory A Kaltsas Department of Pathophysiology, Neuroendocrine Tumor Unit, Oxford Centre for Diabetes, National University of Athens, Greece

Search for other papers by Gregory A Kaltsas in
Google Scholar
PubMed Close
,
Simona Grozinsky-Glasberg Department of Pathophysiology, Neuroendocrine Tumor Unit, Oxford Centre for Diabetes, National University of Athens, Greece

Search for other papers by Simona Grozinsky-Glasberg in
Google Scholar
PubMed Close
,
Eleftherios Chatzellis Department of Pathophysiology, Neuroendocrine Tumor Unit, Oxford Centre for Diabetes, National University of Athens, Greece

Search for other papers by Eleftherios Chatzellis in
Google Scholar
PubMed Close
, and
Ashley B Grossman Department of Pathophysiology, Neuroendocrine Tumor Unit, Oxford Centre for Diabetes, National University of Athens, Greece

Search for other papers by Ashley B Grossman in
Google Scholar
PubMed Close

: LN metastases were present in 15% of patients with tumours ≤1.0 cm in diameter, 47% with tumours >1 cm but ≤2 cm in diameter and 86% with tumours >2 cm in diameter ( Mullen & Savarese 2011 ). Treatment The management of aNENs depends on the size and

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-15-0310
Volume/Issue:
Volume 23: Issue 1
Free access
Asterios Karagiannis
Search for other papers by Asterios Karagiannis in
Google Scholar
PubMed Close
,
Dimitri P Mikhailidis Division of Endocrinology, Department of Clinical Biochemistry,, Second Propedeutic Department of Internal Medicine, Medical School, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki 54642, Greece

Search for other papers by Dimitri P Mikhailidis in
Google Scholar
PubMed Close
,
Vasilios G Athyros
Search for other papers by Vasilios G Athyros in
Google Scholar
PubMed Close
, and
Faidon Harsoulis
Search for other papers by Faidon Harsoulis in
Google Scholar
PubMed Close

is technically impossible, a repeat noninvasive localization work-up after 2–6 months is a more attractive and preferable choice. Management After precise localization, surgical removal of the tumor should follow with the expectation that all symptoms

Article Type:
Research Article
DOI:
https://doi.org/10.1677/ERC-07-0142
Volume/Issue:
Volume 14: Issue 4
Free access
Maria P Yavropoulou Endocrinοlogy Unit, 1st Department of Propaedeutic Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Maria P Yavropoulou in
Google Scholar
PubMed Close
,
Marina Tsoli Endocrinοlogy Unit, 1st Department of Propaedeutic Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Marina Tsoli in
Google Scholar
PubMed Close
,
Konstantinos Barkas Department of Neurosurgery, General Hospital of Nikaia-Peiraia, Agios Panteleimon, Athens, Greece

Search for other papers by Konstantinos Barkas in
Google Scholar
PubMed Close
,
Gregory Kaltsas Endocrinοlogy Unit, 1st Department of Propaedeutic Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Gregory Kaltsas in
Google Scholar
PubMed Close
, and
Ashley Grossman Centre for Endocrinology, Barts and the London School of Medicine, Queen Mary University of London, London, UK
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK

Search for other papers by Ashley Grossman in
Google Scholar
PubMed Close

, ranging between 10% and 38% on CT imaging and 4–20% on MRI compared to the incidence of macroadenomas (range between 0.16% on MRI and 0.3% on CT) ( Freda et al. 2011 ). The management of NFpitNETs includes replacement hormonal therapy in the presence

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-20-0136
Volume/Issue:
Volume 27: Issue 10
Free access
Rossella Libè
Search for other papers by Rossella Libè in
Google Scholar
PubMed Close
,
Amato Fratticci
Search for other papers by Amato Fratticci in
Google Scholar
PubMed Close
, and
Jérôme Bertherat
Search for other papers by Jérôme Bertherat in
Google Scholar
PubMed Close

improve diagnosis, prognosis evaluation, and treatment. This review will summarize the advances in the molecular mechanisms of adrenocortical tumors development that have recently been made and the current clinical management of ACC

Article Type:
Review Article
DOI:
https://doi.org/10.1677/erc.1.01130
Volume/Issue:
Volume 14: Issue 1
Free access
Mohid S Khan Neuroendocrine Tumour Unit, Centre for Gastroenterology, Royal Free Hospital, 10th Floor, London NW3 2QG, UK

Search for other papers by Mohid S Khan in
Google Scholar
PubMed Close
and
Martyn E Caplin Neuroendocrine Tumour Unit, Centre for Gastroenterology, Royal Free Hospital, 10th Floor, London NW3 2QG, UK

Search for other papers by Martyn E Caplin in
Google Scholar
PubMed Close

. Management should be guided by the Consensus Guidelines for Management of NETs, for example those produced by the European Neuroendocrine Tumour Society (ENETS). In low- and intermediate-grade metastatic midgut NETs, somatostatin analogues are the mainstay of

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-10-0271
Volume/Issue:
Volume 18: Issue S1
Free access
Cosimo Durante
Search for other papers by Cosimo Durante in
Google Scholar
PubMed Close
,
Giuseppe Costante Department of Internal Medicine and Medical Specialties, Department of Internal Medicine, Department of Health Sciences, University of Rome ‘Sapienza’, Viale del Policlinico 155, 00161 Rome, Italy
Department of Internal Medicine and Medical Specialties, Department of Internal Medicine, Department of Health Sciences, University of Rome ‘Sapienza’, Viale del Policlinico 155, 00161 Rome, Italy

Search for other papers by Giuseppe Costante in
Google Scholar
PubMed Close
, and
Sebastiano Filetti
Search for other papers by Sebastiano Filetti in
Google Scholar
PubMed Close

appropriate, cost-effective management of the current generation of DTCs. Table 1 Paradigm shifts in the management of differentiated thyroid cancers Old paradigms Current paradigms a Future paradigms What is the appropriate operation for DTCs? Total

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-13-0066
Volume/Issue:
Volume 20: Issue 4
Free access
Fadi Nabhan Division of Endocrinology, Diabetes and Metabolism, The Ohio State University College of Medicine, Wexner Medical Center, Arthur G. James Comprehensive Cancer Center, Columbus, Ohio, USA

Search for other papers by Fadi Nabhan in
Google Scholar
PubMed Close
and
Matthew D Ringel Division of Endocrinology, Diabetes and Metabolism, The Ohio State University College of Medicine, Wexner Medical Center, Arthur G. James Comprehensive Cancer Center, Columbus, Ohio, USA

Search for other papers by Matthew D Ringel in
Google Scholar
PubMed Close

data by panels of clinical and research experts from nearly all specialties involved in the care of patients with thyroid cancer. Most guidelines are updated periodically to reflect additional data that influence clinical management over time. However

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-16-0432
Volume/Issue:
Volume 24: Issue 2
Free access